MET and non-small cell lung carcinoma: In the current scientific literature, many studies have described the occurrence of general somatic mutations in NSCLC, although some niche mutations, such as c-MET and RET in adenocarcinoma of the lung have been described in a few short reports [19–22], or in a larger population focusing on a single-niche mutation of PIK3CA [23–25].